SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-022011
Filing Date
2019-04-17
Accepted
2019-04-17 17:23:00
Documents
2
Period of Report
2019-04-17

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5091
2 EX-24.1 ex-24d1.htm EX-24.1 9972
  Complete submission text file 0001104659-19-022011.txt   16436
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HOOKIPA PHARMA INC. 430 EAST 29TH ST., 14TH FLOOR NEW YORK NY 10016
Business Address
Lilja Anders (Reporting) CIK: 0001768216 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38869 | Film No.: 19753788